Joram, Nicolas
Beqiri, Erta
Pezzato, Stefano
Moscatelli, Andrea
Robba, Chiara
Liet, Jean-Michel
Chenouard, Alexis
Bourgoin, Pierre
Czosnyka, Marek
Léger, Pierre-Louis
Smielewski, Peter
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of Arterial Carbon Dioxide and Oxygen Content on Cerebral Autoregulation Monitoring Among Children Supported by ECMO
https://doi.org/10.1007/s12028-021-01201-8
Continuous Monitoring of Cerebral Autoregulation in Children Supported by Extracorporeal Membrane Oxygenation: A Pilot Study
https://doi.org/10.1007/s12028-020-01111-1
Article History
Received: 6 July 2020
Accepted: 9 September 2020
First Online: 8 October 2020
Change Date: 2 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12028-023-01727-z
Conflict of Interest
: Joram has nothing to disclose. Beqiri has nothing to disclose. Pezzato has nothing to disclose. Moscatelli has nothing to disclose. Robba has nothing to disclose. Liet has nothing to disclose. Chenouard has nothing to disclose. Bourgoin has nothing to disclose. Czosnyka reports personal fees from Cambridge Enterprise Ltd, UK, during the conduct of the study. Léger has nothing to disclose. Smielewski reports and receives part of licensing fees for the brain monitoring software ICM+ (Cambridge Enterprise Ltd, Cambridge, UK) used in this project.
: The study was approved by the local Ethics Committees. Information of the parents was provided before inclusion.
: ClinicalTrials.gov (NCT04282525, February 21, 2020) ExternalRef removed